Bacterial bile salt hydrolase in host metabolism: Potential for influencing gastrointestinal microbe-host crosstalk

Gut Microbes

Volumn 5, Issue 5, 2014, Pages 669-674

  Joyce, Susan A ^a,b   Shanahan, Fergus ^a   Hill, Colin ^a,c   Gahan, Cormac G M ^a,c  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bile; Circadian rhythm; Lactobacillus; Obesity; Probiotic

Indexed keywords

BACTERIAL ENZYME; BILE ACID; BILE ACID CONJUGATE; BILE SALT HYDROLASE; CHOLESTEROL; LIPOPOLYSACCHARIDE; PROBIOTIC AGENT; UNCLASSIFIED DRUG; AMIDASE; BACTERIAL PROTEIN; CHOLOYLGLYCINE HYDROLASE;

AKKERMANSIA MUCINOPHILA; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; BILE ACID METABOLISM; BILIRUBIN BINDING; CIRCADIAN RHYTHM; DIET SUPPLEMENTATION; ENERGY METABOLISM; ENZYME ACTIVITY; GASTROINTESTINAL TRACT; GENE EXPRESSION; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; LACTOBACILLUS; LACTOBACILLUS REUTERI; LIPID METABOLISM; LISTERIA INNOCUA; MALNUTRITION; METAGENOMICS; MICROBIAL COMMUNITY; MOLECULAR INTERACTION; NONHUMAN; OBESITY; SARCOPENIA; SIGNAL TRANSDUCTION; WEIGHT GAIN; WEIGHT REDUCTION; ANIMAL; ANIMAL MODEL; BACTERIUM; BODY WEIGHT; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); LACTOBACILLUS;

AMIDOHYDROLASES; ANIMALS; BACTERIA; BACTERIAL PROTEINS; BODY WEIGHT; CHOLESTEROL; CIRCADIAN RHYTHM; GASTROINTESTINAL TRACT; MICE; MODELS, ANIMAL;

EID: 84922021716     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/19490976.2014.969986     Document Type: Article

References (53)

1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/ 10.1038/nature08821
2. Tong M, Li X, Wegener Parfrey L, Roth B, Ippoliti A, Wei B, et al. A modular organization of the human intestinal mucosal microbiota and its association with inflammatory bowel disease. PLoS One 2013; 8: e80702; PMID:24260458; http://dx.doi.org/10.1371/ journal.pone.0080702
3. Karlsson FH, Tremaroli V, Nookaew I, Bergstrom G, Behre CJ, Fagerberg B, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013; 498:99-103; PMID: 23719380; http://dx.doi.org/10.1038/nature12198
4. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-6; PMID:23985870; http://dx.doi.org/ 10.1038/nature12506
5. Joyce SA, Gahan CG. The gut microbiota and the metabolic health of the host. Curr Opin Gastroenterol 2014; 30:120-7; PMID:24468803; http://dx.doi.org/ 10.1097/MOG.0000000000000039
6. Angelakis E, Merhej V, Raoult D. Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infect Dis 2013; 13:889-99; PMID:24070562; http://dx.doi.org/10.1016/S1473- 3099(13)70179-8
7. Clarke SF, Murphy EF, Nilaweera K, Ross PR, Shanahan F, O'Toole PW, et al. The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes 2012; 3:186-202; PMID:22572830; http:// dx.doi.org/10.4161/gmic.20168
8. Nieuwdorp M, Gilijamse PW, Pai N, Kaplan LM. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014; 146:1525-33; PMID: 24560870; http://dx.doi.org/10.1053/j.gastro.2014.02.008
9. Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013; 27:73- 83; PMID:23768554; http://dx.doi.org/10.1016/j. bpg.2013.03.007
10. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-31; PMID:17183312; http:// dx.doi.org/10.1038/nature05414
11. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444:1022-3; PMID:17183309; http:// dx.doi.org/10.1038/4441022a
12. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59:1635-42; PMID:20926643; http://dx.doi.org/ 10.1136/gut.2010.215665
13. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013; 341:1241214; PMID:24009397; http://dx.doi. org/10.1126/science.1241214
14. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007; 56:1761-72; PMID:17456850; http://dx.doi.org/10.2337/db06-1491
15. Creely SJ, McTernan PG, Kusminski CM, Fisher M, Da Silva NF, Khanolkar M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 2007; 292:E740-7; PMID: 17090751; http://dx.doi.org/10.1152/ajpendo.00302.2006
16. Karlsson CL, Onnerfalt J, Xu J, Molin G, Ahrne S, Thorngren-Jerneck K. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 2012; 20:2257-61; PMID: 22546742; http://dx.doi.org/10.1038/oby.2012.110
17. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls dietinduced obesity. Proc Natl Acad Sci U S A 2013; 110:9066-71; PMID:23671105; http://dx.doi.org/ 10.1073/pnas.1219451110
18. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-β-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17:225-35; PMID:23395169; http://dx. doi.org/10.1016/j.cmet.2013.01.003
19. Watanabe M, Houten SM,Mataki C, ChristoffoleteMA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006; 439:484-9; PMID:16400329; http:// dx.doi.org/10.1038/nature04330
20. Joyce SA, MacSharry J, Casey PG, Kinsella M, Murphy EF, Shanahan F, et al. Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut. Proc Natl Acad Sci U S A 2014; 111:7421- 6; PMID:24799697; http://dx.doi.org/10.1073/ pnas.1323599111
21. Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005; 29:625- 51; PMID:16102595; http://dx.doi.org/10.1016/j. femsre.2004.09.003
22. Begley M, Hill C, Gahan CG. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006; 72:1729-38; PMID:16517616; http://dx.doi.org/ 10.1128/AEM.72.3.1729-1738.2006
23. Lin J. Antibiotic growth promoters enhance animal production by targeting intestinal bile salt hydrolase and its producers. Front Microbiol 2014; 5:33; PMID:24575079;.
24. Smith K, Zeng X, Lin J. Discovery of bile salt hydrolase inhibitors using an efficient high-throughput screening system. PLoS One 2014; 9:e85344; PMID:24454844; http://dx.doi.org/10.1371/journal.pone.0085344
25. Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 2008; 105:13580-5; PMID:18757757; http://dx.doi.org/10.1073/pnas. 0804437105
26. Fang F, Li Y, Bumann M, Raftis EJ, Casey PG, Cooney JC, et al. Allelic variation of bile salt hydrolase genes in Lactobacillus salivarius does not determine bile resistance levels. J Bacteriol 2009; 191:5743-57; PMID: 19592587; http://dx.doi.org/10.1128/JB.00506-09
27. de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab 2013; 17:657-69; PMID:23602448; http://dx.doi.org/ 10.1016/j.cmet.2013.03.013
28. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006; 25:1419-25; PMID: 16541101; http://dx.doi.org/10.1038/sj.emboj.7601049
29. Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4523- 30; PMID:20837534; http://dx.doi.org/10.1073/ pnas.1006734107
30. Jones ML, Tomaro-Duchesneau C, Martoni CJ, Prakash S. Cholesterol lowering with bile salt hydrolaseactive probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 2013; 13:631-42; PMID:23350815; http://dx.doi.org/10.1517/14712598. 2013.758706
31. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011; 334:255-8; PMID:21998396; http://dx.doi.org/10.1126/science.1209791
32. Islam KB, Fukiya S, Hagio M, Fujii N, Ishizuka S, Ooka T, et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141:1773-81; PMID:21839040; http://dx.doi.org/10.1053/j.gastro.2011.07.046
33. Yokota A, Fukiya S, Islam KB, Ooka T, Ogura Y, Hayashi T, et al. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes 2012; 3:455-9; PMID:22825495; http://dx.doi.org/10.4161/gmic. 21216
34. Inagaki T, Moschetta A, Lee YK, Peng L, Zhao G, Downes M, et al. Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc Natl Acad Sci U S A 2006; 103:3920-5; PMID: 16473946; http://dx.doi.org/10.1073/pnas.0509592103
35. Ichikawa R, Takayama T, Yoneno K, Kamada N, Kitazume MT, Higuchi H, et al. Bile acids induce monocyte differentiation toward interleukin-12 hypoproducing dendritic cells via a TGR5-dependent pathway. Immunology 2012; 136:153-62; PMID: 22236403; http://dx.doi.org/10.1111/j.1365-2567.2012. 03554.x
36. Ryan KK, Tremaroli V, Clemmensen C, Kovatcheva- Datchary P, Myronovych A, Karns R, et al. FXR is a molecular target for the effects of vertical sleeve gastrectomy. Nature 2014; 509:183-8; PMID:24670636; http://dx.doi.org/10.1038/nature13135
37. Backhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to dietinduced obesity in germ-free mice. Proc Natl Acad Sci U S A 2007; 104:979-84; PMID:17210919; http://dx. doi.org/10.1073/pnas.0605374104
38. Bass J. Circadian topology of metabolism. Nature 2012; 491:348-56; PMID:23151577; http://dx.doi. org/10.1038/nature11704
39. Ekmekcioglu C, Touitou Y. Chronobiological aspects of food intake and metabolism and their relevance on energy balance and weight regulation. Obes Rev 2011; 12:14-25; PMID:20122134; http://dx.doi.org/ 10.1111/j.1467-789X.2010.00716.x
40. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell 2013; 153:812-27; PMID:23663780; http://dx. doi.org/10.1016/j.cell.2013.04.020
41. Li YC, Wang DP, Chiang JY. Regulation of cholesterol 7 α-hydroxylase in the liver. Cloning, sequencing, and regulation of cholesterol 7 α-hydroxylase mRNA. J Biol Chem 1990; 265:12012-9; PMID:1694852;.
42. Zhang YK, Guo GL, Klaassen CD. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PLoS One 2011; 6:e16683
43. Degirolamo C, Rainaldi S, Bovenga F, Murzilli S, Moschetta A. Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in mice. Cell Rep 2014; 7:12-8; PMID:24656817; http://dx.doi.org/10.1016/j.celrep. 2014.02.032
44. Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr 2012; 66:1234-41; PMID:22990854; http://dx.doi.org/10.1038/ejcn.2012.126
45. Li F, Jiang C, Krausz KW, Li Y, Albert I, Hao H, et al. Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 2013; 4:2384; PMID:24064762;.
46. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, et al. Microbiotagenerated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014; 156:84-96; PMID: 24412651; http://dx.doi.org/10.1016/j.cell.2013.12.016
47. Choi SB, Lew LC, Yeo SK, Nair Parvathy S, Liong MT. Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario. Crit Rev Biotechnol 2014; PMID:24575869;.
48. Ajouz H, Mukherji D, Shamseddine A. Secondary bile acids: an underrecognized cause of colon cancer. World J Surg Oncol 2014; 12:164; PMID:24884764; http:// dx.doi.org/10.1186/1477-7819-12-164
49. Maran RR, Thomas A, Roth M, Sheng Z, Esterly N, Pinson D, et al. Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development. J Pharmacol Exp Ther 2009; 328:469-77; PMID:18981289; http://dx.doi. org/10.1124/jpet.108.145409
50. Modica S, Murzilli S, Salvatore L, Schmidt DR,Moschetta A. Nuclear bile acid receptor FXR protects against intestinal tumorigenesis. Cancer Res 2008; 68:9589-94; PMID: 19047134; http://dx.doi.org/10.1158/0008-5472.CAN-08-1791
51. Guban J, Korver DR, Allison GE, Tannock GW. Relationship of dietary antimicrobial drug administration with broiler performance, decreased population levels of Lactobacillus salivarius, and reduced bile salt deconjugation in the ileum of broiler chickens. Poult Sci 2006; 85:2186-94; PMID:17135676; http://dx.doi. org/10.1093/ps/85.12.2186
52. Vrieze A, Out C, Fuentes S, Jonker L, Reuling I, Kootte RS, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 2014; 60:824-31; PMID:24316517; http://dx.doi.org/ 10.1016/j.jhep.2013.11.034
53. Wang Z, Zeng X, Mo Y, Smith K, Guo Y, Lin J. Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters. Appl Environ Microbiol 2012; 78:8795-802; PMID:23064348; http://dx.doi.org/10.1128/AEM.02519-12